Association of blood pressure with genetic variation in WNK kinases in a white European population

Circulation

Volumn 112, Issue 22, 2005, Pages 3371-3372

  Zhang, Haifeng ^a,b   Staessen, Jan A ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; Cardiovascular diseases; Editorials; Hypertension genetics

Indexed keywords

PHOSPHOTRANSFERASE; PROTEIN KINASE WNK1; PROTEIN KINASE WNK4; UNCLASSIFIED DRUG; WNK KINASE; PROTEIN SERINE THREONINE KINASE; WNK1 PROTEIN, HUMAN;

BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; EDITORIAL; EUROPE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; WNK GENE; WNK1 GENE; WNK4 GENE; BLOOD PRESSURE; CAUCASIAN; ETHNOLOGY; FAMILY HEALTH; GENETICS; NOTE; PHYSIOLOGY; PSEUDOHYPOALDOSTERONISM;

BLOOD PRESSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY HEALTH; HUMANS; HYPERTENSION; PROTEIN-SERINE-THREONINE KINASES; PSEUDOHYPOALDOSTERONISM; VARIATION (GENETICS);

EID: 33644876156     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.585737     Document Type: Editorial

References (18)

1. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-1112.
2. Xu B, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH. WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem. 2000;275:16795-16801.
3. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proc Natl Acad Sci U S A. 2003;100:680-684.
4. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest. 2003;111:1039-1045.
5. + secretion. Nat Genet. 2003;35:372-376.
6. - permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension. Proc Natl Acad Sci U S A. 2004;101:14877-14882.
7. Golbang AP, Murthy M, Hamad A, Liu CH, Cope G, Van't Hoff W, Cuthbert A, O'Shaughnessy KM. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. Hypertension. 2005;46:295-300.
8. Yamauchi K, Rai T, Kobayashi K, Sohara E, Suzuki T, Itoh T, Suda S, Hayama A, Sasaki S, Uchida S. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci U S A. 2004;101:4690-4694.
9. Xu BE, Stippec S, Chu PY, Lazrak A, Li XJ, Lee BH, English JM, Ortega B, Huang CL, Cobb MH. WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci U S A. 2005;102:10315-10320.
10. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van Sligtenhorst I, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci U S A. 2003;100:14109-14114.
11. Erlich PM, Cui J, Chazaro I, Farrer LA, Baldwin CT, Gavras H, DeStefano AL. Genetic variants of WNK4 in whites and African Americans with hypertension. Hypertension. 2003;41:1191-1195.
12. Speirs HJ, Morris BJ. WNK4 intron 10 polymorphism is not associated with hypertension. Hypertension. 2004;43:766-768.
13. Kokubo Y, Kamide K, Inamoto N, Tanaka C, Banno M, Takiuchi S, Kawano Y, Tomoike H, Miyata T. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population. J Hum Genet. 2004;49:507-515.
14. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Connell JM, Webster J, Lathrop GM, Caulfield M, Munroe PB. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Hum Mol Genet. 2005;14:1805-1814.
15. Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, Cross D, Gracey J, Hayes S, Smith T, Ridge C, Caulfield M, Sheehan NA, Munroe PB, Burton PR, Samani NJ. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation. 2005;112:3423-3429.
16. O'Reilly M, Marshall E, Speirs HJ, Brown RW. WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain. J Am Soc Nephrol. 2003;14:2447-2456.
17. - flux in extrarenal epithelia. Proc Natl Acad Sci U S A. 2004;101:2064-2069.
18. Kuznetsova T, Staessen JA, Brand E, Cwynar M, Stolarz K, Thijs L, Tikhonoff V, Wojciechowska W, Babeanu S, Brand-Herrmann SM, Casiglia E, Filipovsky J, Grodzicki T, Nikitin Y, Peleška J, Struijker-Boudier H, Bianchi G, Kawecka-Jaszcz K; European Project On Genes in Hypertension (EPOGH) Investigators. Sodium excretion as modulator of genetic associations with cardiovascular phenotypes in the European Project on Genes in Hypertension. J Hypertens. In press.